Breaking News

Cenduit Launches New Trial Supply Service

December 5, 2012

Simulation and forecasting designed to better control supplies

Cenduit LLC has introduced a new study simulation and forecasting service designed to allow clinical trial sites to better plan and control supplies for patients. The new service is integrated with the company’s interactive response technology (IRT).
 
“Clinical trials are more complex than ever and a robust and reliable clinical trial supply strategy is vital to study success,” said Jogin Desai, Cenduit’s chief executive officer. “The simulation and forecasting models, integrated with the patient randomization and drug allocation services inherent in our IRT systems, allow the complete coordination of procurement, packaging and logistics, with supply requirements from the sites themselves continuously factored in.”
 
Mr. Desai added that new system helps minimize the risk of drug supply overage and shortages at sites and helps accelerate drug development through increased supply chain productivity.

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • Clinical Trial Supplies 101: Outsourcing Primer for Virtual Pharma and Biopharma Companies, Part II

    Clinical Trial Supplies 101: Outsourcing Primer for Virtual Pharma and Biopharma Companies, Part II

    Alex McClung, Xcelience||November 13, 2014
    Getting packaged investigational materials dispensed to the patients taking part in clinical trials, on time and correctly, requires orchestrating myriad activities. This is the second in a series of articles outlining specific quality concerns associated with packaging clinical trial supplies and how to effectively manage those concerns.

  • Drug Supply Shortages in Clinical Trials

    Drug Supply Shortages in Clinical Trials

    John Burns , BioClinica||November 13, 2014
    Impacts on studies and how to avoid them.